Michael Busch-Sørensen

454 total citations
22 papers, 368 citations indexed

About

Michael Busch-Sørensen is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Michael Busch-Sørensen has authored 22 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Michael Busch-Sørensen's work include Cancer Immunotherapy and Biomarkers (10 papers), Thyroid Disorders and Treatments (3 papers) and Ferroptosis and cancer prognosis (2 papers). Michael Busch-Sørensen is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Thyroid Disorders and Treatments (3 papers) and Ferroptosis and cancer prognosis (2 papers). Michael Busch-Sørensen collaborates with scholars based in Denmark, United States and United Kingdom. Michael Busch-Sørensen's co-authors include Jens Faber, C. Kirkegaard, Blake B. Rasmussen, Henrik Westh, Ingelise Jensen, Wei Zhou, Niels K. Veien, Kenneth Emancipator, Peter Meldgaard and Henrik Hager and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Cancer Research and Journal of Neurochemistry.

In The Last Decade

Michael Busch-Sørensen

21 papers receiving 354 citations

Peers

Michael Busch-Sørensen
C Grohé Germany
Michael J. Zdon United States
Jessica K. Devin United States
Kenneth Wilhelm United States
Kelli D. Salter United States
John F. Hennessy United States
C Grohé Germany
Michael Busch-Sørensen
Citations per year, relative to Michael Busch-Sørensen Michael Busch-Sørensen (= 1×) peers C Grohé

Countries citing papers authored by Michael Busch-Sørensen

Since Specialization
Citations

This map shows the geographic impact of Michael Busch-Sørensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Busch-Sørensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Busch-Sørensen more than expected).

Fields of papers citing papers by Michael Busch-Sørensen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Busch-Sørensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Busch-Sørensen. The network helps show where Michael Busch-Sørensen may publish in the future.

Co-authorship network of co-authors of Michael Busch-Sørensen

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Busch-Sørensen. A scholar is included among the top collaborators of Michael Busch-Sørensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Busch-Sørensen. Michael Busch-Sørensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Høgdall, Estrid, Claus Høgdall, Wei Zhou, et al.. (2020). Impact of PD-L1 and T-cell inflamed gene expression profile on survival in advanced ovarian cancer. International Journal of Gynecological Cancer. 30(7). 1034–1042. 8 indexed citations
2.
Steiniche, Torben, Morten Ladekarl, Simon Andreasen, et al.. (2020). Association of PD-L1 Expression with Prognosis Among Patients with Ten Uncommon Advanced Cancers. Future Science OA. 6(8). FSO616–FSO616. 9 indexed citations
3.
Eriksen, Jesper Grau, Stine Rosenkilde Larsen, Jonathan D. Cheng, et al.. (2020). Prognostic impact of PD-L1 in oropharyngeal cancer after primary curative radiotherapy and relation to HPV and tobacco smoking. Acta Oncologica. 59(6). 666–672. 11 indexed citations
4.
Steiniche, Torben, Morten Ladekarl, Simon Andreasen, et al.. (2018). Association of PD-L1 expression with prognosis among patients with 10 select cancers. Annals of Oncology. 29. viii15–viii15.
5.
Steiniche, Torben, Jesper Grau Eriksen, Michael Busch-Sørensen, et al.. (2018). Programmed death-ligand 1 (PD-L1) expression and HPV-associated p16 in oropharyngeal squamous cell carcinoma (OSCC) treated with primary curative radiotherapy (RT). Annals of Oncology. 29. viii386–viii386. 1 indexed citations
6.
Høgdall, Estrid, Claus Høgdall, Wei Zhou, et al.. (2017). PD-L1 expression and prognosis significance in advanced ovarian cancer. Annals of Oncology. 28. v333–v333. 1 indexed citations
7.
Zhou, Wei, Marisa Dolled‐Filhart, Zhen Wang, et al.. (2016). PD-L1 Expression and Survival among Patients with Advanced Non–Small Cell Lung Cancer Treated with Chemotherapy. Translational Oncology. 9(1). 64–69. 78 indexed citations
8.
Steiniche, Torben, Zhen Wang, Patricia Switten Nielsen, et al.. (2015). Abstract 4303: Programmed death ligand 1 (PD-L1) expression in paired melanoma tumor samples. Cancer Research. 75(15_Supplement). 4303–4303. 1 indexed citations
9.
Green, Anders, Dena Rosen Ramey, Martha Emneus, et al.. (2014). Incidence of Cancer and Mortality in Patients from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Trial. The American Journal of Cardiology. 114(10). 1518–1522. 20 indexed citations
10.
Sørensen, Steen, Wei Zhou, Marisa Dolled‐Filhart, et al.. (2014). Pd-L1 Expression and Survival Among Advanced Non–Small Cell Lung Cancer (Nsclc) Patients Treated with Chemotherapy. Annals of Oncology. 25. iv467–iv467. 4 indexed citations
11.
Steiniche, Torben, Patricia Switten Nielsen, Lars Bastholt, et al.. (2014). Pd-L1 Expression and Overall Survival Among Patients with Melanoma. Annals of Oncology. 25. iv380–iv380. 1 indexed citations
12.
Zhou, Wei, Michael Busch-Sørensen, Tim Demuth, et al.. (2010). Abstract P3-12-09: Numb Expression Varies by Hormone Receptor Status among Danish Breast Cancer Patients. Cancer Research. 70(24_Supplement). P3–12. 1 indexed citations
13.
Veien, Niels K., et al.. (2005). Montelukast treatment of moderate to severe atopic dermatitis in adults: A randomized, double-blind, placebo-controlled trial. Journal of the American Academy of Dermatology. 53(1). 147–149. 28 indexed citations
14.
Raymond, Ilan, Frants Pedersen, Michael Busch-Sørensen, Anders Green, & Per Hildebrandt. (2002). The Frederiksberg Heart Failure Study: Rationale, Design and Methodology, with Special Emphasis on the Sampling Procedure for the Study Population and Its Comparison to the Background Population. 2(4). 167–174. 14 indexed citations
15.
Busch-Sørensen, Michael, et al.. (1995). Diabetes Care: a Guideline to the Facilities Needed to Support Internationally Endorsed Standards. Diabetic Medicine. 12(9). 833–838. 3 indexed citations
16.
Lyngsøe, J., et al.. (1992). The Effect of Sustained Release Verapamil on Glucose Metabolism in Patients with Non-Insulin-Dependent Diabetes Mellitus. Drugs. 44(Supplement 1). 85–87. 7 indexed citations
17.
Busch-Sørensen, Michael, Jens J. Holst, & J. Lyngsøe. (1991). Short time effects of growth hormone on glucose metabolism and insulin and glucagon secretion in normal man. Journal of Endocrinological Investigation. 14(1). 25–30. 1 indexed citations
18.
Busch-Sørensen, Michael, et al.. (1989). Regional Distribution of Neuropeptide Y and Its Receptor in the Porcine Central Nervous System. Journal of Neurochemistry. 52(5). 1545–1552. 31 indexed citations
19.
Faber, Jens, C. Kirkegaard, Blake B. Rasmussen, et al.. (1987). Pituitary-Thyroid Axis in Critical Illness*. The Journal of Clinical Endocrinology & Metabolism. 65(2). 315–320. 105 indexed citations
20.
Lumholtz, I B, Michael Busch-Sørensen, Jens Faber, et al.. (1979). The Influence of Propranolol on the Extrathyroidal Metabolism of 3,3‘,5’‐Triiodothyronine (Reverse T3). Acta Medica Scandinavica. 205(S624). 31–34. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026